uniQure NV (QURE)
24.51
-14.60
(-37.33%)
USD |
NASDAQ |
Sep 29, 16:00
24.88
+0.37
(+1.51%)
Pre-Market: 08:39
uniQure Price to Book Value : 5.244 for Sept. 29, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 5.244 |
| September 28, 2026 | 8.368 |
| September 25, 2026 | 8.180 |
| September 24, 2026 | 8.199 |
| September 23, 2026 | 9.149 |
| September 22, 2026 | 9.688 |
| September 21, 2026 | 9.481 |
| September 18, 2026 | 9.414 |
| September 17, 2026 | 9.434 |
| September 16, 2026 | 9.091 |
| September 15, 2026 | 9.222 |
| September 14, 2026 | 9.613 |
| September 11, 2026 | 9.524 |
| September 10, 2026 | 9.515 |
| September 09, 2026 | 9.842 |
| September 08, 2026 | 9.774 |
| September 04, 2026 | 9.521 |
| September 03, 2026 | 9.598 |
| September 02, 2026 | 9.892 |
| September 01, 2026 | 10.24 |
| August 31, 2026 | 10.42 |
| August 28, 2026 | 10.42 |
| August 27, 2026 | 10.60 |
| August 26, 2026 | 10.90 |
| August 25, 2026 | 10.92 |
| Date | Value |
|---|---|
| August 24, 2026 | 10.15 |
| August 21, 2026 | 10.35 |
| August 20, 2026 | 10.46 |
| August 19, 2026 | 10.43 |
| August 18, 2026 | 10.14 |
| August 17, 2026 | 10.26 |
| August 14, 2026 | 10.40 |
| August 13, 2026 | 10.07 |
| August 12, 2026 | 9.656 |
| August 11, 2026 | 9.628 |
| August 10, 2026 | 9.855 |
| August 07, 2026 | 9.932 |
| August 06, 2026 | 9.705 |
| August 05, 2026 | 9.466 |
| August 04, 2026 | 9.346 |
| August 03, 2026 | 9.427 |
| July 31, 2026 | 9.335 |
| July 30, 2026 | 9.027 |
| July 29, 2026 | 8.574 |
| July 28, 2026 | 7.844 |
| July 27, 2026 | 8.176 |
| July 24, 2026 | 8.338 |
| July 23, 2026 | 8.437 |
| July 22, 2026 | 8.640 |
| July 21, 2026 | 8.578 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Kymera Therapeutics, Inc. | 6.062 |
| Sarepta Therapeutics, Inc. | 1.289 |
| Twist Bioscience Corp. | 26.17 |
| GRAIL, Inc. | 2.399 |
| Arrowhead Pharmaceuticals, Inc. | 20.09 |
Price to Book Value Related Metrics
| PS Ratio | 81.99 |
| PEG Ratio | -1.865 |
| Price | 24.51 |
| Earnings Yield | -16.52% |
| Market Cap | 1.699B |
| PEGY Ratio | -1.865 |